,25 Moreover, PF-07209960 was shown to stimulate proliferation of colorectal cancer (CRC) PD-1+ CD8+ TILs preferentially over other lymphocytes, suggesting there may be a potential for activity even in a tumor type considered traditionally resistant to immune-based therapies.24 This evidence concerns the gene CD8A and neoplasm.